111 related articles for article (PubMed ID: 32014926)
21. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase.
Milczarek M; Rossowska J; Klopotowska D; Stachowicz M; Kutner A; Wietrzyk J
J Steroid Biochem Mol Biol; 2019 Jun; 190():139-151. PubMed ID: 30923017
[TBL] [Abstract][Full Text] [Related]
22. Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D.
Belorusova AY; Suh N; Lee HJ; So JY; Maehr H; Rochel N
J Steroid Biochem Mol Biol; 2017 Oct; 173():69-74. PubMed ID: 27650654
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.
Thill M; Fischer D; Becker S; Cordes T; Dittmer C; Diedrich K; Salehin D; Friedrich M
Anticancer Res; 2009 Sep; 29(9):3619-25. PubMed ID: 19667157
[TBL] [Abstract][Full Text] [Related]
24. Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer.
Abd-Rabou AA; Bharali DJ; Mousa SA
Pharm Res; 2018 Feb; 35(4):76. PubMed ID: 29488022
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
[TBL] [Abstract][Full Text] [Related]
26. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages.
Hoshiba T; Tanaka M
Biochem Biophys Res Commun; 2013 Sep; 439(2):291-6. PubMed ID: 23978418
[TBL] [Abstract][Full Text] [Related]
28. The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells.
Brenner RV; Shabahang M; Schumaker LM; Nauta RJ; Uskokovic MR; Evans SR; Buras RR
Cancer Lett; 1995 May; 92(1):77-82. PubMed ID: 7757962
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
30. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Banwell CM; MacCartney DP; Guy M; Miles AE; Uskokovic MR; Mansi J; Stewart PM; O'Neill LP; Turner BM; Colston KW; Campbell MJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2004-13. PubMed ID: 16609009
[TBL] [Abstract][Full Text] [Related]
31. Influence of calcitriol on prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cell lines.
Thill M; Cordes T; Hoellen F; Becker S; Dittmer C; Kümmel S; Salehin D; Friedrich M; Diedrich K; Köster F
Anticancer Res; 2012 Jan; 32(1):359-65. PubMed ID: 22213327
[TBL] [Abstract][Full Text] [Related]
32. The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
Brosseau C; Colston K; Dalgleish AG; Galustian C
Apoptosis; 2012 Feb; 17(2):164-73. PubMed ID: 22109882
[TBL] [Abstract][Full Text] [Related]
33. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
34. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
35. AZD4547 and calcitriol synergistically inhibited BT-474 cell proliferation while modified stemness and tumorsphere formation.
Morales-Guadarrama G; Méndez-Pérez EA; García-Quiroz J; Avila E; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2022 Oct; 223():106132. PubMed ID: 35659529
[TBL] [Abstract][Full Text] [Related]
36. Modulation of expression of heat shock proteins and apoptosis by Flueggea leucopyrus (Willd) decoction in three breast cancer phenotypes.
Mendis AS; Thabrew I; Samarakoon SR; Tennekoon KH
BMC Complement Altern Med; 2015 Nov; 15():404. PubMed ID: 26553005
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D receptor as a target for breast cancer therapy.
Murray A; Madden SF; Synnott NC; Klinger R; O'Connor D; O'Donovan N; Gallagher W; Crown J; Duffy MJ
Endocr Relat Cancer; 2017 Apr; 24(4):181-195. PubMed ID: 28213567
[TBL] [Abstract][Full Text] [Related]
38. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
39. Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells.
Chekhun SV; Lukyanova NY; Shvets YV; Burlaka AP; Buchinska LG
Exp Oncol; 2014 Sep; 36(3):179-83. PubMed ID: 25265351
[TBL] [Abstract][Full Text] [Related]
40. Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors.
Banwell CM; O'Neill LP; Uskokovic MR; Campbell MJ
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):245-9. PubMed ID: 15225779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]